In the genes - Gene-cell therapies
Duchenne Muscular Dystrophy can devastate a person’s life, resulting in mobility limitation and heart failure. Now, the latest in gene technology is being used to offer targeted therapies to patients in order to bring expertise to this vital area.
The cellular level – eNAMPT stimulation
A build-up of Nicotinamide Adenine Dinucleotide (NAD) in the body can result in the onset of various diseases and poor health outcomes. The University of Manchester have developed a new series of small molecule compounds, specifically designed to stimulate eNAMPT dimerization and have demonstrated these have potent activity leading to a corrective effect in in vitro and in vivo phenotypic models of diabetes. These could also have benefits in the treatment of a number of other diseases.
Digital doctors - VREvo Ltd
With cutting-edge technology as sharp as a scalpel, VREvo Ltd has the means to train a new generation of healthcare professionals with virtual reality, using simulated surgeons, pretend patients, and all manner of virtual organs to get results.
Health and Biotech
A vision of success - Complement Therapeutics Ltd
Taking on two devastating immune system diseases, AMD and GA, Complement Therapeutics Ltd is developing new strategies to enhance one of the most promising areas in patient care.